DHR Health MS Center
McAllen, Texas 78501
1 studies enrolling now · 1 studies all time
What they study most
Multiple Sclerosis
Studies at this site
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
— Recruiting now